Literature DB >> 6776899

Endotoxin in meningococcal infections.

H R Tubbs.   

Abstract

26 children with meningococcal infections were studied to find out the relationaship between plasma and cerebrospinal fluid levels of endotoxin, the clinical outcome, the level of antigen in plasma and cerebrospinal fluid, and indices of complement activation and disseminated intravascular coagulation. No association was found between endotoxin levels and the other factors. A high cerebrospinal fluid antigen level in patients with meningitis was associated with a poor prognosis.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6776899      PMCID: PMC1626918          DOI: 10.1136/adc.55.10.808

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  8 in total

1.  Cerebrospinal fluid endotoxin concentrations in gram-negative bacterial meningitis.

Authors:  N S Berman; S E Siegel; R Nachum; A Lipsey; J Leedom
Journal:  J Pediatr       Date:  1976-04       Impact factor: 4.406

2.  The role of complement in endotoxin-induced disseminated intravascular coagulation: studies in congenitally C6-deficient rabbits.

Authors:  G Müller-Berghaus; E Lohmann
Journal:  Br J Haematol       Date:  1974-11       Impact factor: 6.998

3.  Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections.

Authors:  B M Greenwood; H C Whittle; O Dominic-Rajkovic
Journal:  Lancet       Date:  1971-09-04       Impact factor: 79.321

4.  Gram-negative sepsis: detection of endotoxemia with the limulus test. With studies of associated changes in blood coagulation, serum lipids, and complement.

Authors:  J Levin; T E Poore; N S Young; S Margolis; N P Zauber; A S Townes; W R Bell
Journal:  Ann Intern Med       Date:  1972-01       Impact factor: 25.391

5.  Detection of endotoxin in human blood and demonstration of an inhibitor.

Authors:  J Levin; P A Tomasulo; R S Oser
Journal:  J Lab Clin Med       Date:  1970-06

6.  Meningococcal antigen in diagnosis and treatment of group A meningococcal infections.

Authors:  H C Whittle; B M Greenwood; N Davidson; A Tomkins; P Tugwell; D A Warrell; A Zalin; A D BRYCESON; E H Parry; M Brueton; M Duggan; J M Oomen; A D Rajkovic
Journal:  Am J Med       Date:  1975-06       Impact factor: 4.965

7.  Hemodynamic changes in endotoxin shock.

Authors:  S Chien; C Chang; R J Dellenback; S Usami; M I Gregersen
Journal:  Am J Physiol       Date:  1966-06

8.  Prognostic factors in acute meningococcaemia.

Authors:  L S Lewis
Journal:  Arch Dis Child       Date:  1979-01       Impact factor: 3.791

  8 in total
  6 in total

1.  Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange.

Authors:  R S Pedersen; O L Pedersen; I Nielsen; K Stengaard-Petersen
Journal:  Br Med J (Clin Res Ed)       Date:  1984-07-28

2.  Endotoxin liberation by strains of N. meningitidis isolated from patients and healthy carriers.

Authors:  M C Mellado; R Rodríguez-Contreras; M Fernandez-Crehuet; R Lopez-Gigosos; M Delgado Rodriguez; R Galvez-Vargas
Journal:  Epidemiol Infect       Date:  1991-04       Impact factor: 2.451

3.  Complement abnormalities during an epidemic of group B meningococcal infection in children.

Authors:  D W Beatty; C R Ryder; H D Heese
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

4.  Quantitation of endotoxin in blood from patients with meningococcal disease using a limulus lysate test in combination with chromogenic substrate.

Authors:  S Harthug; B Bjorvatn; B Osterud
Journal:  Infection       Date:  1983 Jul-Aug       Impact factor: 3.553

5.  Prognostic factors of severe infectious purpura in children.

Authors:  F Leclerc; R Beuscart; B Guillois; J F Diependaele; G Krim; D Devictor; Y Bompard; T van Albada
Journal:  Intensive Care Med       Date:  1985       Impact factor: 17.440

Review 6.  Endotoxemia: methods of detection and clinical correlates.

Authors:  J C Hurley
Journal:  Clin Microbiol Rev       Date:  1995-04       Impact factor: 26.132

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.